Skip to main content

Coastlands Capital LP's Form 4 filing

Bolt Biotherapeutics, Inc.BOLT · filed Nov 10, 2026

Accession no.
0001104659-26-125077
Filed
Nov 10, 2026, 2:57 PM ET
Trade date
Nov 9, 2026
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market purchases total $319.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Coastlands Capital LPCIK 000206853010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 9, 2026Common StockPPurchaseAcquired+50,000$6.38F1+$319,000462,416Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $6.3618 to $6.4044. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the reporting persons will provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)